ARDUINI, Arduino
 Distribuzione geografica
Continente #
EU - Europa 124
NA - Nord America 42
AS - Asia 13
Totale 179
Nazione #
IT - Italia 68
US - Stati Uniti d'America 41
SE - Svezia 19
FR - Francia 14
IE - Irlanda 12
VN - Vietnam 8
DE - Germania 4
RU - Federazione Russa 4
SG - Singapore 2
TR - Turchia 2
CA - Canada 1
CN - Cina 1
FI - Finlandia 1
NL - Olanda 1
UA - Ucraina 1
Totale 179
Città #
Chieti 35
Stockholm 18
Vittuone 14
Ashburn 13
Dublin 12
Dong Ket 8
Boardman 5
Paris 3
Ankara 2
Hanover 2
Milan 2
San Jose 2
Bassano del Grappa 1
Chandler 1
Chicago 1
Florence 1
Gatchina 1
Helsinki 1
Moscow 1
Mountain View 1
Munich 1
Nanchang 1
Nashville 1
Ottawa 1
Padova 1
Palo Alto 1
Pescara 1
St Petersburg 1
Udine 1
Venice 1
Totale 134
Nome #
L-Carnitine is an osmotic agent suitable for peritoneal dialysis, file e4233f15-a44c-2860-e053-6605fe0a460a 25
null, file e4233f16-2860-2860-e053-6605fe0a460a 22
null, file e4233f17-f259-2860-e053-6605fe0a460a 22
The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis, file e4233f18-bdb6-2860-e053-6605fe0a460a 20
Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells, file e4233f16-ec1f-2860-e053-6605fe0a460a 19
Current opinion on usage of L-carnitine in end-stage renal disease patients on peritoneal dialysis, file e4233f17-49ed-2860-e053-6605fe0a460a 17
How to improve the biocompatibility of peritoneal dialysis solutions (without Jeopardizing the patient’s health), file e4233f18-b1f4-2860-e053-6605fe0a460a 13
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia, file e4233f14-ebf7-2860-e053-6605fe0a460a 11
Carnitine in metabolic disease: potential for pharmacological intervention, file e4233f14-ebf8-2860-e053-6605fe0a460a 7
Alterazioni eritrocitarie e loro possibile ruolo nelle complicanze cardiovascolari dell’uremia, file 492dbd4f-aea2-4827-b6e2-d40e7fe70ace 4
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial., file e4233f15-0503-2860-e053-6605fe0a460a 4
Defining the potential antidepressant mode of action of acetyl-l-carnitine., file e4233f16-db70-2860-e053-6605fe0a460a 3
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia, file e4233f14-ebf6-2860-e053-6605fe0a460a 2
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine, file e4233f14-ebfd-2860-e053-6605fe0a460a 2
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine, file e4233f14-ebfe-2860-e053-6605fe0a460a 2
Carnitine palmitoyltransferase as a potential target for treating diabetes: is inhibition or activation preferable?, file e4233f14-f816-2860-e053-6605fe0a460a 2
Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge, file 1ac3e809-4ae6-44ce-9bfe-e3d555a85be5 1
Erythrocyte alterations and increased cardiovascular risk in chronic renal failure, file 223fabef-56c4-45c7-932a-a445cc0eeafd 1
In vitro microbiology studies on a new peritoneal dialysis connector, file e4233f14-f81b-2860-e053-6605fe0a460a 1
L-carnitine in uremic anemia, file e4233f18-b211-2860-e053-6605fe0a460a 1
Totale 179
Categoria #
all - tutte 638
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 638


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 2 0 0 0 0 0 0 0 9 5 1 0
2020/202121 0 0 0 1 0 1 0 6 3 0 0 10
2021/202222 3 2 3 0 0 1 0 2 2 6 1 2
2022/202377 14 0 6 1 6 10 9 2 5 2 21 1
2023/202439 1 3 2 5 2 9 4 0 8 5 0 0
Totale 179